Investigational Site Number :2760004

Münster 48149

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Multiple Sclerosis

Studies at this site

• Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis — Running, not enrolling
• SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" — Completed